Founded in March 2002 and listed on the Shanghai Stock Exchange in 2017 (Stock Code: 603387), Getein Biotech, Inc. was the first main-board listed company in China's Point-of-Care Testing (POCT) field. Getein focuses on the R&D, production, sales, and services of in vitro diagnostic reagents and instruments. Its core competitiveness is anchored in eight major technology platforms: Point-of-Care Testing (POCT), Chemiluminescence, Clinical Chemistry, Modular System, Coagulation, Hematology, Molecular Diagnostics, and Veterinary Diagnostics, as well as the R&D of quality control materials.
Getein has evolved from an initial focus on traditional, low-throughput immunofluorescence products to a diversified portfolio featuring multi-technology platforms and fully automated, high-throughput systems. These include the Integrated Hematology System, the Immunochemistry and Clinical Chemistry Modular System, and the Integrated Clinical Chemistry and Immunochemistry Modular System. Its comprehensive test menu spans a wide spectrum of clinical areas, including Cardiovascular Disease, Inflammatory Markers, Diabetes, Renal Function, Thyroid Function, Infectious Diseases, Hormones, Bone Metabolism, and Tumor Markers.
Getein has obtained multiple authoritative certifications, including ISO9001:2015, ISO13485:2016, MDSAP and BGMP, ensuring compliance with major global regulatory authorities such as the CE IVDR, US FDA, Brazil ANVISA, UK MHRA, Australia TGA, and Indonesia AKL, etc. As of the end of 2025, the company had acquired a total of 4,420 product registration certificates, including 476 domestic certificates (37 Class III, 388 Class II, and 51 Class I medical devices) and 3,944 overseas registration certificates (covering import permits from 67 countries and regions), laying a solid compliance foundation for its global strategic layout.
After years of deep industry engagement and market presence, Getein has established long-term, stable partnerships with over 3,000 high-quality distributors nationwide and more than 400 overseas distributors, building an extensive distribution network. Supported by this well-established channel system, its products are sold in 130 countries and regions across the globe.
